Clinical Trial Update: Methylprednisolone Injections Treating Birch Pollen Induced Allergic Rhinitis. [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating methylprednisolone injections for birch pollen–induced allergic rhinitis (hay fever).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Hay Fever
• Pollen Allergy
• Seasonal Allergic Rhinitis

Drugs mentioned

• Methylprednisolone injections (methylprednisolone)

Snippet

Sponsor: Karolinska Institutet | Conditions: Rhinitis, Allergic, Seasonal, Hay Fever | Phase 4 | Status: COMPLETED